Skip to main content
. 2008 Mar 12;105(11):4277–4282. doi: 10.1073/pnas.0708647105

Table 1.

Characteristics of AngII-infused HF-fed LDLR−/− mice treated with or without PPARδ ligand

Characteristics HF/AngII HF/AngII/1 mpk GW HF/AngII/10mpk GW
Initial BW (g) 25.5 ± 2.2 26.5 ± 1.3 26.6 ± 1.3
Final BW (g) 21.6 ± 1.4 20.5 ± 1.5 20.1 ± 1.2
Intial BP (mm Hg) 108.0 ± 6.5 100.2 ± 5.9 103.3 ± 6.5
Final BP (mm Hg) 155.6 ± 11.6 168.5 ± 16.8 171.4 ± 14.3
Triglycerides (mg/dL) 160.0 ± 18.2 115.0 ± 8.5* 65.0 ± 14.0*
Cholesterol (mg/dL) 1273 ± 78.7 1035. ± 35.8* 1140 ± 1.3*
HDL (mg/dL) 78.0 ± 2.0 115.0 ± 4.3* 48.0 ± 4.0*
Fatty acids (mg/dL) 58.0 ± 2.0 43.0 ± 1.6* 36.0 ± 1.9*
Glucose (mg/dL) 241.0 ± 16.9 207.0 ± 10.7 153.0 ± 9.6*
Insulin (mg/dL) 762 ± 94 718 ± 109 575 ± 82*
Resistin (pg/mL) 1483 ± 94 1298 ± 160 1112 ± 147
Leptin (pg/mL) 1041 ±72 397 ± 85* 330 ± 82*
MCP-1 (pg/mL) 89.0 ± 20.0 12.2 ± 2.0* 12.1 ± 12.0*
PAI-1 (pg/mL) 4742 ± 316 2337 ± 322* 3630 ± 410

BW, body weight; BP, blood pressure. Means ± SD. *, P < 0.05 vs. HF/AngII.